Latest "Basics Market" News Stories

18:48 EDT 20th July 2019 | BioPortfolio

Here are the most relevant search results for "Basics Market" found in our extensive news archives from over 250 global news sources.

More Information about Basics Market on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Basics Market for you to read. Along with our medical data and news we also list Basics Market Clinical Trials, which are updated daily. BioPortfolio also has a large database of Basics Market Companies for you to search.

Showing "Basics Market" News Articles 1–25 of 11,000+

Friday 19th July 2019

Don't Slash Medicare In Last-Minute Budget Agreement

To raise the debt ceiling, lawmakers proposed to undermine Medicare Part D. It would be a mistake to target Part D, a successful, comparatively free-market program that helps nearly 45 million Americans afford prescriptions. The proposal would hurt vulnerable seniors and stifle medical innovation.

Amedisys Announces Second Quarter Earnings Release and Conference Call Date

BATON ROUGE, La., July 19, 2019 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the second quarter ended June 30, 2019, after the market closes on July 31, 2019.  The Company will host … Continue reading →

Leafbuyer Technologies, Inc. Issues Statement about Promotional Activity Involving Its Common Stock

Leafbuyer Technologies, Inc. ("Leafbuyer" or the "Company") (OTCQB:LBUY), a leading cannabis technology platform, announced that it has been requested by OTC Markets Group, Inc. to comment on recent promotional activity regarding its common stock, which is quoted on OTC Markets. In June 2019, the Company entered into an investor relations agreement with Promethean Marketing, Inc., for a total of ...

Apollo Endosurgery, Inc. to Report Second Quarter Results on July 23, 2019

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended June 30, 2019 on Tuesday, July 23, 2019, after the U.S. stock markets close. Apollo will hold a conference call on Tuesday, July 23, 2019 a...

Afya Educacional (NASDAQ:AFYA) Lists on NASDAQ

Brazil’s largest medical education group seeks to transform medical education Today, Afya Educacional (“Afya” or “the Company”), Brazil’s largest medical education group,1 lists on the Nasdaq under the ticker symbol NASDAQ:AFYA. The initial public offering of 13,744,210 Class A common shares is priced at $19.00 per share. Afya is the first company in its indus

Rising Pharmaceuticals Announces the U.S. Launch of a Generic Version of Pregabalin Capsules

Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company, today announced the U.S. launch & commercial shipment of a generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg. Pregabalin Capsules had U.S. sales of approximately $5,497 million for the 12 months ending March 2019, acc...

US Market For Therapeutic Cancer Biosimilars Will Be Tested By Mvasi, Kanjinti Launches

Amgen and Allergan’s launch of the first biosimilars to Roche/Genentech’s Avastin and Herceptin may not face the same commercial dynamics...  

U.S. Gastro-Intestinal Stromal Tumors Market Report 2019: The Pipeline, Epidemiology, Market Valuations, Drugs (Sales & Market Share), and Competitive Landscape Through 2014-2024 –

DUBLIN–(BUSINESS WIRE)–The “US Gastro-Intestinal Stromal Tumors Market and Competitive Landscape – 2019” report has been added to’s offering. This report provides comprehensive insights into Gastro-Intestinal Stromal Tumors pipeline products, Gastro-Intestinal Stromal Tumors epidemiology, Gastro-Intestinal Stromal Tumors market valuations ...

United States Pruritus Market Report 2019: The Pipeline, Epidemiology, Market Valuations, Drugs (Sales & Market Share), and Competitive Landscape, 2014-2024 –

DUBLIN–(BUSINESS WIRE)–The “US Pruritus Market and Competitive Landscape – 2019” report has been added to’s offering. This report provides comprehensive insights into Pruritus pipeline products, Pruritus epidemiology, Pruritus market valuations and forecast, Pruritus drugs sales and competitive landscape in … Continue reading →

Breast Reconstruction Market Size to Hit USD 3.6 Bn by 2026

Acumen Research and Consulting, recently published report on “Breast reconstruction Market Size, Share, Trends, Scope, Growth and Forecast 2019-2026”. LOS ANGELES, July 19, 2019 (GLOBE NEWSWIRE) Read more...

VCA Animal Hospitals Offers Free Boarding for Pets Displaced by Hurricane Barry

VCA Animal Hospitals announced that select VCA Animal Hospitals in Louisiana are offering free boarding assistance to dogs and cats, and other species, to families with pets who have been impacted by Hurricane Barry. “We want to assist families and their pets who continue to be impacted by severe flooding in the aftermath of Hurricane Barry,” said Doug Drew, President VCA Animal Hospitals a...

Alphatec announces commercial launch of ALIF IdentiTi porous titanium interbody system implant

“The spine market’s new organic innovation machine continues to deliver meaningful clinical distinction,” said Pat Miles, Chairman and Chief Executive Officer. “With this fifth of twelve new product The post Alphatec announces commercial launch of ALIF IdentiTi porous titanium interbody system implant appeared first on NS Medical Devices.

Align Supplement Industry Regulation With DSHEA, Groups Tell FDA In 'Responsible Innovation' Comments

Targeted guidance on questions around NDINs and using import alerts to keep violative products off market are among supplement industry trade...   

Autism 'Cure' Products Spur Comment Wave On FDA's VMS Industry Oversight

More than half the 73 comments posted to FDA's DSHEA modernization docket are from consumers concerned about a specific type...   

Top 5 Vendors in the Global Molecular Biology Enzymes, Kits, and Reagents Market 2019-2023 | Technavio

High incidence of chronic diseases globally and the need for personalized medicine, has encouraged several technological advancements in the form of recombinant DNA that involves genetic combinations of species to treat diseases. The recombinant DNA technology increases the demand for molecular biology enzymes, kits, and reagents as they are required for successful recombinant protein expression ...

Top 5 Vendors in the Mercury Analyzer Market from 2019 to 2023 | Technavio

LONDON–(BUSINESS WIRE)–#Biotechnology–Several government bodies across the world are enforcing stringent regulations to tackle the adverse environmental effects of mercury emission. Mercury analyzers help in measuring furnace temperature and the flue gas of air pollutants. Thus, the enforcement of strict regulations … Continue reading →

Top 5 Vendors in the Global Non-small Cell Lung Cancer Drugs Market 2019-2023 | Technavio

Predictive biomarkers can reduce unnecessary treatment and adverse effects unlike chemotherapy and targeted therapies which may cause toxic effects. The development of drugs using predictive biomarkers is being approved for the treatment of advanced stage non-small cell lung cancer. Predictive biomarkers will continue to gain popularity as they help in the development of cost-effective therapies ...

Orion Corporation: Managers’ transactions – Virve Laitinen

ORION CORPORATION      MANAGERS’ TRANSACTIONS 19 July 2019 at 15.45 EETS Orion Corporation: Managers’ transactions – Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion … Continue reading →

Yield Growth Enters European Market, Setting Itself Up for Global Success -- CFN Media

Seattle, Washington--(Newsfile Corp. - July 19, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces pu...

Challenges facing the US biosimilars market

At the 17th Biosimilar Medicines Conference in The Netherlands, Dr Gillian Woolett of US healthcare consultancy Avalere Health discussed challenges facing the biosimilars market in the US and upcoming changes in the Food and Drug Administration (FDA).

Columbia Care Announces Launch of Share Repurchase Program

Company’s board of directors approves $25 million open market repurchase program Columbia Care Inc. (NEO:CCHW) (OTCQX:CCHWF) (FSE:3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced its intention to commence a normal course issuer bid (the “Repurchase Program...

Celltrion Sets Up JV With Nan Fung To Sell Biosimilars In China

Celltrion is pushing into biosimilar market opportunities in China by setting up a joint venture with local player Nan Fung...   

Amgen, Allergan launch first US biosimilars of Roche's Herceptin and Avastin

Market entry of the copycat drugs will test Roche's preparation for competition to what for years have been among its top-selling products.

Servier Option Termination Fails To Dent MacroGenics’ Flotetuzumab Optimism

The French firm has handed back rights to MacroGenics’ lead DART candidate flotetuzumab. Undaunted, MacroGenics is forging ahead with clinical...    

Downstream processing market will grow to record $40bn by 2026

The global downstream processing market is predicted to witness record-breaking growth due to a surge in the adoption of biotech processes. The post Downstream processing market will grow to record $40bn by 2026 appeared first on

Quick Search

News Quicklinks